Shigeki Sugii
PhD
Senior Principal Investigator
👥Biography 个人简介
Shigeki Sugii has advanced iPSC technology in Singapore through research on the epigenetic memory of reprogrammed cells and its impact on differentiation potential, which has important implications for selecting optimal source cells for iPSC-derived cancer therapies. His work on metabolic programming of iPSCs has revealed how culture conditions influence the functional properties of iPSC-derived immune cells. He has contributed to establishing iPSC banking initiatives in Asia that aim to provide immunologically matched cell sources for diverse populations.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Shigeki Sugii 的研究动态
Follow Shigeki Sugii's research updates
留下邮箱，当我们发布与 Shigeki Sugii（Agency for Science, Technology and Research (A*STAR) Singapore）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment